Chemical Component Summary

Name4-({(1S)-2-(azetidin-1-yl)-1-[4-chloro-3-(trifluoromethyl)phenyl]ethyl}amino)quinazoline-8-carboxamide
Identifiers4-[[(1~{S})-2-(azetidin-1-yl)-1-[4-chloranyl-3-(trifluoromethyl)phenyl]ethyl]amino]quinazoline-8-carboxamide
FormulaC21 H19 Cl F3 N5 O
Molecular Weight449.857
TypeNON-POLYMER
Isomeric SMILESc1cc2c(c(c1)C(=O)N)ncnc2N[C@H](CN3CCC3)c4ccc(c(c4)C(F)(F)F)Cl
InChIInChI=1S/C21H19ClF3N5O/c22-16-6-5-12(9-15(16)21(23,24)25)17(10-30-7-2-8-30)29-20-14-4-1-3-13(19(26)31)18(14)27-11-28-20/h1,3-6,9,11,17H,2,7-8,10H2,(H2,26,31)(H,27,28,29)/t17-/m1/s1
InChIKeyHXAUJHZZPCBFPN-QGZVFWFLSA-N

Chemical Details

Formal Charge0
Atom Count50
Chiral Atom Count1
Bond Count53
Aromatic Bond Count17

Drug Info: DrugBank

DrugBank IDDB15431 
NameM-2698
Groups investigational
DescriptionM-2698 is under investigation in clinical trial NCT01971515 (First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies).
Synonyms
  • MSC2363318A
  • M-2698
CAS number1379545-95-5

Related Resource References

Resource NameReference
Pharos CHEMBL4871106
PubChem 89808643
ChEMBL CHEMBL4871106